GB202114190D0 - Compositions for preventing and/or treating demyelination - Google Patents

Compositions for preventing and/or treating demyelination

Info

Publication number
GB202114190D0
GB202114190D0 GBGB2114190.8A GB202114190A GB202114190D0 GB 202114190 D0 GB202114190 D0 GB 202114190D0 GB 202114190 A GB202114190 A GB 202114190A GB 202114190 D0 GB202114190 D0 GB 202114190D0
Authority
GB
United Kingdom
Prior art keywords
compositions
preventing
treating demyelination
demyelination
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2114190.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MJN US Holdings LLC
Original Assignee
MJN US Holdings LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MJN US Holdings LLC filed Critical MJN US Holdings LLC
Priority to GBGB2114190.8A priority Critical patent/GB202114190D0/en
Publication of GB202114190D0 publication Critical patent/GB202114190D0/en
Priority to PCT/EP2022/077465 priority patent/WO2023057386A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2114190.8A 2021-10-04 2021-10-04 Compositions for preventing and/or treating demyelination Ceased GB202114190D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2114190.8A GB202114190D0 (en) 2021-10-04 2021-10-04 Compositions for preventing and/or treating demyelination
PCT/EP2022/077465 WO2023057386A1 (en) 2021-10-04 2022-10-03 Compositions for preventing and/or treating demyelination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2114190.8A GB202114190D0 (en) 2021-10-04 2021-10-04 Compositions for preventing and/or treating demyelination

Publications (1)

Publication Number Publication Date
GB202114190D0 true GB202114190D0 (en) 2021-11-17

Family

ID=78497761

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2114190.8A Ceased GB202114190D0 (en) 2021-10-04 2021-10-04 Compositions for preventing and/or treating demyelination

Country Status (2)

Country Link
GB (1) GB202114190D0 (en)
WO (1) WO2023057386A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4676048B2 (en) * 2000-07-10 2011-04-27 生化学工業株式会社 Demyelinating disease treatment
KR20210079376A (en) * 2016-01-13 2021-06-29 주식회사 베네비오 Composition for Increasing PGC-1 Alpha Expression
KR20190130720A (en) * 2018-05-15 2019-11-25 (주)에이피테크놀로지 Composition for prevention of stroke with 2'-fucosyllactose
EP3934657A4 (en) * 2019-03-05 2023-01-04 Glycom A/S Human milk oligosaccharides for use in enhancing executive function
CN111096455A (en) * 2020-01-15 2020-05-05 浙江科技学院 Total nutrient formula food for resisting senile dementia
CN113413461A (en) * 2021-06-17 2021-09-21 林德球 Medicine for resisting senile dementia and its preparing method

Also Published As

Publication number Publication date
WO2023057386A1 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
IL288914A (en) Compositions and methods for treating cancer
IL286350A (en) Compositions and methods for treating cancer
GB201919382D0 (en) Compositions and methods for preventing or treating muscle conditions
SG11202100076RA (en) Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
SG11202012070YA (en) Methods and compositions for preventing or treating tissue calcification
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
SG11202012343TA (en) Methods and compositions for treating and/or preventing the progression and/or onset of age-related neurodegeneration
ZA202104870B (en) Methods and compositions for treating cancer
IL285886A (en) Compositions and methods for treating laminopathies
IL287982A (en) Compositions and methods for treating cancer
EP4171606A4 (en) Compositions and methods for the treatment of covid-19
IL299295A (en) Methods and compositions for treating hemophilia
IL285796A (en) Methods and compositions for treating
IL286153A (en) Methods and compositions for treating cancer
GB202001422D0 (en) Compositions and methods for preventing or treating nephrolithiasis
PT3810128T (en) Compositions for treating and/or preventing protein-aggregation diseases
GB202114190D0 (en) Compositions for preventing and/or treating demyelination
GB201913122D0 (en) Compositions and methods for treatment of cholangiocarcinoma
IL311266A (en) Compositions and methods for treating or preventing autoimmune diseases
IL285036A (en) Methods and compositions for treating cancer
EP4058043A4 (en) Compositions and methods for treating or preventing crohn's disease
EP4149508A4 (en) Compositions and methods for treating cancer
IL277015A (en) Methods and compositions for treating bile duct paucity-associated conditions
GB201913121D0 (en) Compositions and methods for treatment of cholangiocarcinoma
SG10202104159TA (en) Compositions and Methods for Treating or Preventing Viral Infections

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)